S-1 - Phio Pharmaceuticals Corp. (0001533040) (Filer)

1 min to read

S-1 – Phio Pharmaceuticals Corp. (0001533040) (Filer)

Filed: 2023-04-28 AccNo: 0001683168-23-002765 Size: 312 KB
Source: S-1 – Phio Pharmaceuticals Corp. (0001533040) (Filer)

Insight Acquisition Corp Stockholders Approve Extension of Business Combination Period Through March 7, 2025

NEW YORK, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Insight Acquisition Corp. (NASDAQ: INAQ) announced today that its stockholders have approved...
Tavia Acquisition Corp. Announces Closing of $100 Million Initial Public Offering

London, United Kingdom, December 6.- Tavia Acquisition Corp. (the “Company”) (NASDAQGM:TAVIU) announced today the closing of its initial public offering...
The Game Has Changed: 15% Of All Office Space Inquiries Are For Flexible Office Now

For as long as there have been office leases, tenant rep brokers have earned the highest commissions when their clients...
Shepherd Ave Capital Acquisition Corp Announces Closing of Initial Public Offering

Wilmington, DE, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Shepherd Ave Capital Acquisition Corporation (NASDAQ: SPHAU) (“SPHA” or the “Company”) announced...
S-4/A – ReShape Lifesciences Inc. (0001427570) (Filer)

Filed: 2024-12-06 AccNo: 0001104659-24-125983 Size: 26 MB Source: S-4/A - ReShape Lifesciences Inc. (0001427570) (Filer)